Predict your next investment

Venture Capital
norwichventures.com

See what CB Insights has to offer

Investments

31

Portfolio Exits

2

Funds

1

About Norwich Ventures

Norwich Ventures is a venture capital firm that helps entrepreneurs, healthcare professionals and inventors build innovative medical device companies. Norwich invests early in a company's life, often when it is just an idea.

Norwich Ventures Headquarter Location

1601 Trapelo Road Suite 145

Waltham, Massachusetts, 02451,

United States

(781) 890-2161

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Norwich Ventures News

IONpath Raises $18M in Series B Financing

Sep 28, 2020

IONpath, Inc. , a Menlo Park, Calif.-based developer of high-definition spatial proteomics, closed a $18m Series B financing. The round was led by Samsara BioCapital, with participation from new investor Bruker Corporation, and existing major investors Genoa Ventures, ND Capital, Paladin Partners Investments, Trancos IONpath Investors, Norwich Ventures, and Vertical Venture Partners Growth Fund. The company intends to use the funds to continue to expand operations and its business reach. Led by Sander Gubbens, PhD, CEO, IONpath is a developer of high-definition spatial proteomics, innovating tissue imaging and analysis to accelerate medical discovery and improve human health. Its multiplexed ion beam imaging) platform enables a deeper understanding of the tissue microenvironment with multiplexed, quantitative single-cell analysis. With MIBI technology and the expertise of world-class pathology and data science teams, the company provides actionable insights to translational and clinical researchers at pharmaceutical, biotechnology, and research organizations in immuno-oncology, immunology, neuroscience, and infectious disease research. FinSMEs 28/09/2020

Norwich Ventures Investments

31 Investments

Norwich Ventures has made 31 investments. Their latest investment was in Ionpath as part of their Series B on September 9, 2020.

CBI Logo

Norwich Ventures Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

9/24/2020

Series B

Ionpath

$18M

Yes

8

8/19/2020

Series B - IV

Podimetrics

$8.05M

No

1

5/9/2019

Series B - II

Podimetrics

$13.4M

No

5

1/9/2017

Series A

Subscribe to see more

$99M

Subscribe to see more

10

5/25/2016

Series D - II

Subscribe to see more

$99M

Subscribe to see more

10

Date

9/24/2020

8/19/2020

5/9/2019

1/9/2017

5/25/2016

Round

Series B

Series B - IV

Series B - II

Series A

Series D - II

Company

Ionpath

Podimetrics

Podimetrics

Subscribe to see more

Subscribe to see more

Amount

$18M

$8.05M

$13.4M

$99M

$99M

New?

Yes

No

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

8

1

5

10

10

Norwich Ventures Portfolio Exits

2 Portfolio Exits

Norwich Ventures has 2 portfolio exits. Their latest portfolio exit was Seen Digital Media on June 06, 2018.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

6/6/2018

Acquired

$99M

2

10/8/2012

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

6/6/2018

10/8/2012

Exit

Acquired

Acquired

Companies

Subscribe to see more

Valuation

$99M

$99M

Acquirer

Subscribe to see more

Sources

2

10

Norwich Ventures Fund History

1 Fund History

Norwich Ventures has 1 fund, including Norwich Co-Investment Partners LP.

Closing Date

Fund

Fund Type

Status

Amount

Sources

8/2/2010

Norwich Co-Investment Partners LP

Early-Stage Venture Capital

Open

$11M

1

Closing Date

8/2/2010

Fund

Norwich Co-Investment Partners LP

Fund Type

Early-Stage Venture Capital

Status

Open

Amount

$11M

Sources

1

Norwich Ventures Team

1 Team Member

Norwich Ventures has 1 team member, including current Founder, Managing Director, Aaron Sandoski.

Name

Work History

Title

Status

Aaron Sandoski

DEKA Research & Development, Express Scripts, and McKinsey & Company

Founder, Managing Director

Current

Name

Aaron Sandoski

Work History

DEKA Research & Development, Express Scripts, and McKinsey & Company

Title

Founder, Managing Director

Status

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.